Aevius launches with $22 million led by Insight Partners to make patient data computable
Mass General Brigham spinout Aevius launched with $22 million led by Insight Partners to build AI models of multimodal patient histories for health systems, payers and life sciences firms.
Aevius launches with $22 million led by Insight Partners to make patient data computable
Aevius, a Boston clinical intelligence company spun out of Mass General Brigham, launched on November 17, 2026 with $22 million in funding led by Insight Partners. The company builds AI models that learn from structured, unstructured and multimodal medical data. Its core product is a refreshable multimodal patient representation, a continuously updated picture of a patient's clinical state and trajectory. The founders are CEO Rowland Pettit, CTO Ming Yang (Max) Lu, Faisal Mahmood and Long Phi Le, who previously built Modella AI, which AstraZeneca acquired. Eric Topol chairs the Scientific Advisory Board.
The launch adds a new model builder to health AI, with a hospital system as spinout parent and a large growth investor as lead. Aevius targets three groups. Health systems can use it for clinical research, care planning and resource planning. Payers can use it to follow patient needs over time. Life sciences companies can use it to study disease progression, identify biomarkers and find trial participants. Insight Partners Managing Director Dylan Morris called Aevius a rare combination of talent and technology.
For builders, the stated product is a patient representation layer, with applications such as outcome forecasting, similar-patient search, population stratification and change monitoring built on top of it. For investors, the round backs a team with a prior exit in clinical AI. Aevius says the money will go toward model and product development, growth of its engineering, clinical and commercial teams, and commercial deployment.
#Aevius #HealthcareAI #SeedFunding #InsightPartners #MassGeneralBrigham #ClinicalAI